Your Doctor has been thinking about the amount of high risk and high impact research carried out within the UK. The role of both corporate blue skies and a good fraction of public funding must include investments into basic, long-term, radical, and potentially highly disruptive (risky, contentious) research that the incumbent commercial players simply cannot justify to their own shareholders or backers. If they could, they would. Too often though we see such funding being corralled by the research roadmaps of the existing commercial actors.
展开▼
